News & Events about Iradimed Corp.
WINTER SPRINGS, Fla., March 06, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the Company) (NASDAQ: IRMD) today announced that Roger Susi, President and Chief Executive Officer of the Company, will be presenting at the 35th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi is scheduled for a ...
Reports fourth quarter 2022 revenue of $14.9 million, GAAP diluted EPS of $0.29 and non-GAAP diluted EPS of $0.32.Reports full-year 2022 revenue of $53.3 million, GAAP diluted EPS of $1.02 and non-GAAP diluted EPS of $1.10.The Board of Directors approved a special cash dividend of $1.05 per share. ...
WINTER SPRINGS, Fla., Jan. 26, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION(NASDAQ: IRMD) announced today that the Company will release its 2022 fourth quarter financial results before the market opens on Thursday, February 2, 2023. IRADIMED management will host a conference call the same day ...
Reports preliminary fourth quarter 2022 revenue of $14.9 millionAnnounces full-year and first-quarter 2023 financial guidance WINTER SPRINGS, Fla., Jan. 18, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the Company) (NASDAQ: IRMD) today announced selected preliminary financial results for the ...
Announces Preliminary Financial Results for Third Quarter 2022WINTER SPRINGS, Fla., Oct. 10, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION(the Company) (NASDAQ: IRMD) today announced that the Company voluntarily withdrew its 510(K) application on October 5, 2022, for its next-generation MR IV pump. ...